(Nasdaq: GUTS) (the Company or Fractyl), a metabolic therapeutics company focused on pattern breaking approaches that treat root causes of obesity and type 2 diabetes (T2D), today announced groundbreaking results from the REMAIN-1 Midpoint Cohort, supporting the potential for Revita to be the first therapy to preserve weight loss after GLP-1 drug discontinuation
BPC-157 is a fragment of body protection compound, a peptide found in gastric juices that helps protect against stomach ulcers
This is a natural product
When you weave these into your diet, you're building a foundation that will support you for many years to come
We love that it carries the National Eczema Association (NEA) Seal of Acceptance, which indicates that the designated product meets the required scientific criteria and is deemed safe for people with eczema and sensitive skin
Safety standards include: Verified sterile preparation areas CE-marked syringes and pharmaceutical-grade vials Clinical record keeping and follow-up scheduling Adherence to Save Face and GHP accreditations No IV drips or unregulated compounds are used only licensed B12 formulations appropriate for intramuscular use